EU Crunch Time Nears For Amgen’s Novel Lung Cancer Drug Sotorasib

 
• By Ian Schofield

The European Medicines Agency is expected to make recommendations on EU marketing authorization for 10 new medicines at its monthly meeting this week. They include products for non-small cell lung cancer, COVID-19, kidney disease, smallpox and migraine.

Multiple pills forming the flag of the EU.
Many new drugs are awaiting a recommendation on EU approval this week • Source: Alamy

More from Europe

More from Geography